Race, insurance status linked to job loss after breast cancer

by Neil Schoenherr,Washington University in St. LouisCredit: Washington University in St. LouisJob loss following early-stage breast cancer diagnosis is associated with race and insurance status

Updated on: April 07,2024 16

Race, insurance status linked to job loss after breast cancer

by Neil Schoenherr,Washington University in St. LouisCredit: Washington University in St. LouisJob loss following early-stage breast cancer diagnosis is associated with race and insurance status

Updated on:April 07,2024 16

Experts band together to eradicate prostate cancer

by Monash UniversityProstate cancer is surprising difficult to keep alive outside the human body. Yet, like a greenhouse full of rare plants, the Melbourne Urological Research Alliance (MURAL) ha

Updated on: April 07,2024 20

Experts band together to eradicate prostate cancer

by Monash UniversityProstate cancer is surprising difficult to keep alive outside the human body. Yet, like a greenhouse full of rare plants, the Melbourne Urological Research Alliance (MURAL) ha

Updated on:April 07,2024 20

Treatment for recurrent uterine cancer advances to next research phase

by Yale Cancer Center/Smilow Cancer HospitalCredit: Pixabay/CC0 Public DomainThe latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanc

Updated on: August 27,2024 0

Treatment for recurrent uterine cancer advances to next research phase

by Yale Cancer Center/Smilow Cancer HospitalCredit: Pixabay/CC0 Public DomainThe latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanc

Updated on:August 27,2024 0

New imaging detects deadly lung and prostate cancers, may improve treatment

by Jim Stallard,Memorial Sloan Kettering Cancer CenterA new imaging technology developed in the laboratories of Dr. Jason Lewis and Dr. Charles Rudin could improve detection and treatment of cer

Updated on: July 08,2024 0

New imaging detects deadly lung and prostate cancers, may improve treatment

by Jim Stallard,Memorial Sloan Kettering Cancer CenterA new imaging technology developed in the laboratories of Dr. Jason Lewis and Dr. Charles Rudin could improve detection and treatment of cer

Updated on:July 08,2024 0

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Updated on: June 28,2024 7

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Updated on:June 28,2024 7

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on: August 28,2024 0

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on:August 28,2024 0

Increased mitochondria and lipid turnover reduces risk for liver cancer

by University of Chicago Medical CenterLoss of BNIP3 promotes HCC initiation and tumor growth. (A) Representative images of HCC tumors forming in the liver of Bnip3+/+and bnip3−/−mice

Updated on: February 23,2024 17

Increased mitochondria and lipid turnover reduces risk for liver cancer

by University of Chicago Medical CenterLoss of BNIP3 promotes HCC initiation and tumor growth. (A) Representative images of HCC tumors forming in the liver of Bnip3+/+and bnip3−/−mice

Updated on:February 23,2024 17

Study identifies a genetic driver of deadly prostate cancer

by Cedars-Sinai Medical CenterGraph shows elevated activity of a transcription-factor network that includes the molecule Onecut2 in tumors of patients whose prostate cancer resisted hormone thera

Updated on: March 12,2024 19

Study identifies a genetic driver of deadly prostate cancer

by Cedars-Sinai Medical CenterGraph shows elevated activity of a transcription-factor network that includes the molecule Onecut2 in tumors of patients whose prostate cancer resisted hormone thera

Updated on:March 12,2024 19

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on: March 30,2024 0

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on:March 30,2024 0

Immune evasion tactics of liver cancer cells revealed

byeLifeActivated ß-catenin represses immune infiltration in liver cancer spheroids through exosomes. (a) Peripheral Blood Mononuclear Cells (PBMC) infiltration analysis protocol. Created with Bi

Updated on: March 30,2024 0

Immune evasion tactics of liver cancer cells revealed

byeLifeActivated ß-catenin represses immune infiltration in liver cancer spheroids through exosomes. (a) Peripheral Blood Mononuclear Cells (PBMC) infiltration analysis protocol. Created with Bi

Updated on:March 30,2024 0

Study: Anti-PD-L1 antibody enhances curative effect of cryoablation

by Compuscript LtdGraphical abstract. Credit:Acta Pharmaceutica Sinica B(2022). DOI: 10.1016/j.apsb.2022.08.006A new article published inActa Pharmaceutica Sinica Bdiscusses ho

Updated on: January 30,2024 10

Study: Anti-PD-L1 antibody enhances curative effect of cryoablation

by Compuscript LtdGraphical abstract. Credit:Acta Pharmaceutica Sinica B(2022). DOI: 10.1016/j.apsb.2022.08.006A new article published inActa Pharmaceutica Sinica Bdiscusses ho

Updated on:January 30,2024 10

Triplet therapy including belamaf prolongs survival in multiple myeloma

by Elana GotkineFor patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) improves outcomes, with an a

Updated on: March 24,2024 16

Triplet therapy including belamaf prolongs survival in multiple myeloma

by Elana GotkineFor patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) improves outcomes, with an a

Updated on:March 24,2024 16